Overview

A Study of Efavirenz in Combination With Stavudine and Didanosine

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus didanosine to HIV-infected patients who have never received anti-HIV treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Dupont Merck
Treatments:
Didanosine
Efavirenz
Stavudine